Literature DB >> 8088759

Immunohistochemical analysis of cathepsins D, B, and L in human breast cancer.

T Castiglioni1, M J Merino, B Elsner, T T Lah, B F Sloane, M R Emmert-Buck.   

Abstract

Cathepsins D, B, and L are acidic lysosomal proteinases involved in intracellular protein turnover. Increased levels of these enzymes have been reported to be indicators of aggressive tumor behavior in human and rodent tumors. In breast cancer increased levels of cathepsin D have been reported to be an independent prognostic factor in women with stage I disease. We used standard immunohistochemical techniques on formalin-fixed, paraffin-embedded tissue to examine the levels of cathepsins D, B, and L in 80 carcinomas of the breast and compared that with other indicators of aggressive tumor behavior, including stage of disease, tumor size, nuclear grade, estrogen receptor status, disease recurrence, and 5-year survival rates. Positive granular cytoplasmic staining was detected for cathepsin D in 90% of the tumors, for cathepsin B in two thirds of the tumors, and for cathepsin L in approximately one half of the tumors. Positive staining also was seen in normal breast epithelium, areas of apocrine metaplasia, stromal fibroblasts, and macrophages. Our results did not show a correlation between the expression of cathepsins D, B, and L and other indicators of aggressive tumor behavior. We conclude that the results obtained using polyclonal anticathepsin antibodies do not support the prognostic usefulness of immunohistochemical analysis of these three proteinases in tumor cells in human breast cancer.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8088759     DOI: 10.1016/0046-8177(94)90003-5

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  19 in total

1.  Cathepsin B: Basis Sequence: Mouse.

Authors:  Dora Cavallo-Medved; Kamiar Moin; Bonnie Sloane
Journal:  AFCS Nat Mol Pages       Date:  2011-04-10

2.  Signaling From Lysosomes Enhances Mitochondria-Mediated Photodynamic Therapy In Cancer Cells.

Authors:  Geraldine Quiogue; Shalini Saggu; Hsin-I Hung; Malcolm E Kenney; Nancy L Oleinick; John J Lemasters; Anna-Liisa Nieminen
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2009-07-12

3.  Immunohistochemical and clinical evaluation of cathepsin expression in soft tissue sarcomas.

Authors:  P Würl; H Taubert; A Meye; T Dansranjavin; E Weber; D Günther; D Berger; H Schmidt; H Dralle; F W Rath
Journal:  Virchows Arch       Date:  1997-03       Impact factor: 4.064

4.  Prognostic value of cathepsin D in breast cancer: comparison of immunohistochemical and immunoradiometric detection methods.

Authors:  U J Göhring; A Scharl; U Thelen; A Ahr; G Crombach; B R Titius
Journal:  J Clin Pathol       Date:  1996-01       Impact factor: 3.411

5.  Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in mice.

Authors:  Lisa Sevenich; Uta Schurigt; Kathrin Sachse; Mieczyslaw Gajda; Fee Werner; Sebastian Müller; Olga Vasiljeva; Anne Schwinde; Nicole Klemm; Jan Deussing; Christoph Peters; Thomas Reinheckel
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-21       Impact factor: 11.205

6.  The metastatic potential of human pancreatic cell lines in the liver of nude mice correlates well with cathepsin B activity.

Authors:  George N Tzanakakis; Andrew N Margioris; Aristidis M Tsatsakis; Michael P Vezeridis
Journal:  Int J Gastrointest Cancer       Date:  2003

7.  IGFBP-4 anti-angiogenic and anti-tumorigenic effects are associated with anti-cathepsin B activity.

Authors:  María J Moreno; Marguerite Ball; Marina Rukhlova; Jacqueline Slinn; Denis L'abbe; Umar Iqbal; Robert Monette; Martin Hagedorn; Maureen D O'Connor-McCourt; Yves Durocher; Danica B Stanimirovic
Journal:  Neoplasia       Date:  2013-05       Impact factor: 5.715

8.  In vivo investigation of breast cancer progression by use of an internal control.

Authors:  John Baeten; Jodi Haller; Helen Shih; Vasilis Ntziachristos
Journal:  Neoplasia       Date:  2009-03       Impact factor: 5.715

9.  RNA interference-mediated targeting of urokinase plasminogen activator receptor and matrix metalloproteinase-9 gene expression in the IOMM-lee malignant meningioma cell line inhibits tumor growth, tumor cell invasion and angiogenesis.

Authors:  Padmaja Tummalapalli; Christopher S Gondi; Dzung H Dinh; Meena Gujrati; Jasti S Rao
Journal:  Int J Oncol       Date:  2007-07       Impact factor: 5.650

10.  The expression of E-cadherin and cathepsin-D in normal oral mucosa, oral epithelial dysplasia and oral squamous cell carcinoma: A comparative analysis between immunohistochemistry and routine histopathology.

Authors:  Tl Yogesh; Tv Narayan; Balasundari Shreedhar; R Shashidara
Journal:  J Oral Maxillofac Pathol       Date:  2011-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.